[1] LEE R C,FEINBAUM R L,AMBROS V.The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell,1993,75(5):843-854.
[2] BARTEL D P.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
[3] ALVAREZ-GARCIA I,MISKA E A.MicroRNA functions in animal development and human disease[J].Development,2005,132(21):4653-4662.
[4] GONG C,NIE Y,QU S,et al.MiR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors[J].Cancer Res,2014,74(16):4341-4352.
[5] IORIO M V,CROCE C M.MicroRNA dysregulation in cancer:diagnostics,monitoring and therapeutics.A comprehensive review[J].EMBO Mol Med,2012,4(3):143-159.
[6] LÖNNROTH C,ANDERSSON M,ASTING A G,et al.Preoperative low dose NSAID treatment influences the genes for stemness,growth,invasion and metastasis in colorectal cancer[J].Int J Oncol,2014,45(6):2208-2220.
[7] OTHMAN N,NAGOOR N H.The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment[J].Biomed Res Int,2014,2014:318030.
[8] ZHANG B G,LI J F,YU B Q,et al.MicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN[J].Oncol Rep,2012,27(4):1019-1026.
[9] SURGES R,KRETSCHMANN A,ABNAOF K,et al.Changes in serum miRNAs following generalized convulsive seizures in human mesial temporal lobe epilepsy[J].Biochem Biophys Res Commun,2016,481(1-2):13-18.
[10] LIU P,QIU C G,LI B F,et al.Clinical impact of circulating miR-133,miR-1291 and miR-663b in plasma of patients with acute myocardial infarction[J].Diagn Pathol,2014,9:89.
[11] WANDER P L,ENQUOBAHRIE D A,PRITCHARD C C,et al.Circulating microRNAs and sudden cardiac arrest outcomes[J].Resuscitation,2016,106:96-101.
[12] PELLATT D F,STEVENS J R,WOLFF R K,et al.Expression profiles of miRNA subsets distinguish human colorectal carcinoma and normal colonic mucosa[J].Clin Transl Gastroenterol,2016,7(3):e152.
[13] WANG N,ZENG L,LI Z,et al.Serum miR-663 expression and the diagnostic value in colorectal cancer[J].Artif Cells Nanomed Biotechnol,2019,47(1):2650-2653.
[14] PAN C,YAN X,LI H,et al.Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer[J].Oncotarget,2017,8(40):68317-68328.
[15] RAGUSA M,STATELLO L,MAUGERI M,et al.Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors[J].J Mol Med (Berl),2012,90(12):1421-1438.
[16] TRONCONE E,MARAFINI I,STOLFI C,et al.Transforming growth factor-beta1/SMAD7 in intestinal immunity,inflammation,and cancer[J].Front Immunol,2018,9:1407.
[17] TRONCONE E,MONTELEONE G.SMAD7 and colorectal carcinogenesis:a double-edged sword[J].Cancers (Basel),2019,11(5):612.
[18] XIAO F,CHEN W,YU C,et al.MicroRNA-663b enhances migration and invasion by targeting adenomatous polyposis coli 2 in colorectal carcinoma cells[J].Oncology Letters,2020,19(6):3701-3710.
[19] HONG S,YAN Z,WANG H,et al.MiR-663b promotes colorectal cancer progression by activating Ras/Raf signaling through downregulation of TNK1[J].Hum Cell,2020,33(1):104-115.
[20] CHEN Y P,CHAN A T C,LE Q T,et al.Nasopharyngeal carcinoma[J].Lancet,2019,394(10192):64-80.
[21] LIANG S,ZHANG N,DENG Y,et al.Increased serum level of microRNA-663 is correlated with poor prognosis of patients with nasopharyngeal carcinoma[J].Dis Markers,2016,2016:7648215.
[22] WANG M,JIA M,YUAN K.MicroRNA-663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma[J].Exp Ther Med,2018,16(4):3129-3134.
[23] LIANG S,ZHANG N,DENG Y,et al.MiR-663b promotes tumor cell proliferation,migration and invasion in nasopharyngeal carcinoma through targeting TUSC2[J].Exp Ther Med,2017,14(2):1095-1103.
[24] DYRSKJØT L,OSTENFELD M S,BRAMSEN J B,et al.Genomic profiling of microRNAs in bladder cancer:miR-129 is associated with poor outcome and promotes cell death in vitro[J].Cancer Res,2009,69(11):4851-4860.
[25] ICHIMI T,ENOKIDA H,OKUNO Y,et al.Identification of novel microRNA targets based on microRNA signatures in bladder cancer[J].Int J Cancer,2009,125(2):345-52.
[26] DU M,SHI D,YUAN L,et al.Circulating miR-497 and MiR-663b in plasma are potential novel biomarkers for bladder cancer[J].Sci Rep,2015,5:10437.
[27] YIN X,ZHENG X,LIU M,et al.Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells[J].Cell Biol Int,2020,44(4):958-965.
[28] CHEN J,SONG B,KONG G.MicroRNA-663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2[J].Mol Med Rep,2019,19(5):3896-3902.
[29] LIU Y,HE J,CHEN X,et al.The proapoptotic effect of formononetin in human osteosarcoma cells:involvement of inactivation of ERK and Akt pathways[J].Cell Physiol Biochem,2014,34(3):637-645.
[30] WANG Q,CAI J,WANG J,et al.MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion[J].Tumour Biol,2014,35(12):12743-12748.
[31] ISAKOFF M S,BIELACK S S,MELTZER P,et al.Osteosarcoma:current treatment and a collaborative pathway to success[J].J Clin Oncol,2015,33(27):3029-3035.
[32] BOTTI G,GIORDANO A,FEROCE F,et al.Noncoding RNAs as circulating biomarkers in osteosarcoma patients[J].J Cell Physiol,2019,234(11):19249-19255.
[33] SASAKI R,OSAKI M,OKADA F.MicroRNA-based diagnosis and treatment of metastatic human osteosarcoma[J].Cancers (Basel),2019,11(4):553.
[34] ZHAO H,LI M,LI L,et al.MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation,migration and invasion,and promotes apoptosis[J].PLoS One,2013,8(12):e83571.
[35] SHU Y,YE W,GU Y L,et al.Blockade of miR-663b inhibits cell proliferation and induces apoptosis in osteosarcoma via regulating TP73 expression[J].Bratisl Lek Listy,2018,119(1):41-46.
[36] CAI H,AN Y,CHEN X,et al.Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2[J].Oncotarget,2016,7(52):86857-86870.
[37] BURE I V,NEMTSOVA M V,ZALETAEV D V.Roles of E-cadherin and noncoding RNAs in the epithelial-mesenchymal transition and progression in gastric cancer[J].Int J Mol Sci,2019,20(12):2870
[38] LI F Q,XU B,WU Y J,et al.Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer[J].Genet Mol Res,2015,14(1):739-747.
[39] WANG Y L,SHEN Y,XU J P,et al.Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating miR-663b[J].Acta Pharmacol Sin,2017,38(10):1394-1400.
[40] JIANG H,CHENG L,HU P,et al.MicroRNA-663b mediates TAM resistance in breast cancer by modulating TP73 expression[J].Mol Med Rep,2018,18(1):1120-1126.
[41] WANG Y,LI Z,HE C,et al.MicroRNAs expression signatures are associated with lineage and survival in acute leukemias[J].Blood Cells Mol Dis,2010,44(3):191-197.
[42] VASILATOU D,PAPAGEORGIOU S,PAPPA V,et al.The role of microRNAs in normal and malignant hematopoiesis[J].Eur J Haematol,2010,84(1):1-16.
[43] LIU X,ZHANG H,ZHANG B,et al.Expression and role of microRNA-663b in childhood acute lymphocytic leukemia and its mechanism[J].Open Med,2019,14(1):863-871.
[44] JAIN M,ROJANAPORN D,CHAWLA B,et al.Retinoblastoma in Asia[J].Eye (Lond),2019,33(1):87-96.
[45] VENKATESAN N,DEEPA P R,KHETAN V,et al.Computational and in vitro investigation of miRNA-gene regulations in retinoblastoma pathogenesis:miRNA mimics strategy[J].Bioinform Biol Insights,2015,9:89-101. |
